skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

Journal Article · · Science

5-Methylthioadenosine phosphorylase (MTAP) is a key enzyme in the methionine salvage pathway. The MTAP gene is frequently deleted in human cancers because of its chromosomal proximity to the tumor suppressor gene CDKN2A. By interrogating data from a large-scale short hairpin RNA–mediated screen across 390 cancer cell line models, we found that the viability of MTAP-deficient cancer cells is impaired by depletion of the protein arginine methyltransferase PRMT5. MTAP-deleted cells accumulate the metabolite methylthioadenosine (MTA), which we found to inhibit PRMT5 methyltransferase activity. Deletion of MTAP in MTAP-proficient cells rendered them sensitive to PRMT5 depletion. Conversely, reconstitution of MTAP in an MTAP-deficient cell line rescued PRMT5 dependence. Thus, MTA accumulation in MTAP–deleted cancers creates a hypomorphic PRMT5 state that is selectively sensitized toward further PRMT5 inhibition. Inhibitors of PRMT5 that leverage this dysregulated metabolic state merit further investigation as a potential therapy for MTAP/CDKN2A-deleted tumors.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
INDUSTRY
OSTI ID:
1404991
Journal Information:
Science, Vol. 351, Issue 6278; ISSN 0036-8075
Publisher:
AAAS
Country of Publication:
United States
Language:
ENGLISH

References (28)

ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens journal December 2012
DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells journal June 2014
Direct and tumor microenvironment mediated influences of 5′-deoxy-5′-(methylthio)adenosine on tumor progression of malignant melanoma journal February 2009
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers journal February 2014
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models journal April 2015
Overview of the CCP 4 suite and current developments journal March 2011
Vesicular Stomatitis Viruses Resistant to the Methylase Inhibitor Sinefungin Upregulate RNA Synthesis and Reveal Mutations That Affect mRNA Cap Methylation journal February 2007
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity journal March 2012
Structure of the Arginine Methyltransferase PRMT5-MEP50 Reveals a Mechanism for Substrate Specificity journal February 2013
Features and development of Coot journal March 2010
RioK1, a New Interactor of Protein Arginine Methyltransferase 5 (PRMT5), Competes with pICln for Binding and Modulates PRMT5 Complex Composition and Substrate Specificity journal November 2010
PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins journal June 2001
A Transition State Analogue of 5′-Methylthioadenosine Phosphorylase Induces Apoptosis in Head and Neck Cancers journal June 2007
Methylthioadenosine toxicity and metabolism to methionine in mammalian cells journal October 1988
An introduction to data reduction: space-group determination, scaling and intensity statistics journal March 2011
Deregulation of protein methylation in melanoma journal April 2013
Enzyme-Dependent Lysine Deprotonation in EZH2 Catalysis journal September 2013
How good are my data and what is the resolution? journal June 2013
Methylthioadenosine Phosphorylase Regulates Ornithine Decarboxylase by Production of Downstream Metabolites journal September 2003
Salvage of 5′-deoxy-methylthioadenosine into purines and methionine by lymphoid cells and inhibition of cell proliferation journal February 1984
Passenger deletions generate therapeutic vulnerabilities in cancer journal August 2012
Data processing and analysis with the autoPROC toolbox journal March 2011
Crystal structure of the human PRMT5:MEP50 complex journal October 2012
Tumorigenic activity and therapeutic inhibition of Rheb GTPase journal August 2008
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation journal December 2012
Genetic Screens in Human Cells Using the CRISPR-Cas9 System journal December 2013
Full utilization of a mass spectrometer using on-demand sharing with multiple LC units: On-demand sharing of MS journal August 2012
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells journal February 2016

Similar Records

Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion
Journal Article · Thu Apr 08 00:00:00 EDT 2021 · Journal of Medicinal Chemistry · OSTI ID:1404991

The use of methylthioadenosine phosphorylase activity to select for human chromosome 9 in interspecies and intraspecies hybrid cells
Journal Article · Wed Sep 01 00:00:00 EDT 1993 · Somatic Cell and Molecular Genetics; (United States) · OSTI ID:1404991

Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids
Journal Article · Thu Sep 01 00:00:00 EDT 1994 · Somatic Cell and Molecular Genetics · OSTI ID:1404991